Seroprevalence of SARS-Cov-2 Antibodies in Children

CompletedOBSERVATIONAL
Enrollment

1,100

Participants

Timeline

Start Date

May 6, 2020

Primary Completion Date

December 1, 2021

Study Completion Date

November 14, 2023

Conditions
COVIDCorona Virus InfectionMultisystem Inflammatory Syndrome in Children
Interventions
DIAGNOSTIC_TEST

Covid-19 Antibody testing (IgG and IgM)

Antibody testing for previous exposure to Covid-19

OTHER

Blood Storage

Storage of blood for multi-omics analysis

Trial Locations (5)

BT126BA

Royal Belfast Hospital for Sick Children, Belfast

Unknown

University Hospital of Wales, Cardiff

Royal Hospital for Children, Glasgow

Public Health England, London

Public Health England, Manchester

All Listed Sponsors
collaborator

Belfast Health and Social Care Trust

OTHER

lead

Queen's University, Belfast

OTHER

NCT04347408 - Seroprevalence of SARS-Cov-2 Antibodies in Children | Biotech Hunter | Biotech Hunter